Index to Volume 30

Authors

Aazh H, 712, 772, 802

Abrams H, 472

Agrawal SK, 227

Aithal S, 781

Aithal V, 781

Alemi R, 396

Ali YHK, 417

Allan C, 904

Allen P, 904

Ameyaw GA, 178

Anderson S, 781

Andersson G, 31, 472

Anim-Sampong S, 178

Ankmnal-Veeranna S, 904

Arndt S, 607

Arnold ML, 145

Aschendorff A, 607

Azios JH, 31, 810

Azzarello J, 845

Baguley DM, 802

Bailey A, 472

Bakke M, 659

Baldock J, 264

Baldwin J, 845

Balen SA, 6

Barac-Cikoja D, 659

Baril I, 720

Barman A, 753

Behrens T, 634

Bellon-Harn M, 31

Bellon-Harn ML, 810

Benedict C, 856

Bennett ML, 918

Bennett RJ, 516

Beshear D, 493

Bornman M, 217

Brittz M, 482

Brown CRS, 564

Brännström KJ, 169

Bush M, 493

Buñag R, 78

Butera IM, 235

Cameron S, 533

Canale E, 431

Carlson KF, 250

Castillo P, 431

Cañete OM, 564

Chang H-Y, 187

Chen W-X, 672

Chermak G, 451, 735

Chew YY, 346

Chisolm TH, 145

Ciro CA, 845

Cline T, 493

Couture M, 720

Coyle D, 93

Cruickshanks KJ, 282

Côté, 720

Dalton DS, 282

Danesh AA, 772

Daneshi A, 896

Danhauer JL, 677

Davidson LS, 703

Davis A, 208

De Jager LB, 217

Diehm E, 273

Dillard LK, 282, 406

Dockens AL, 31, 810

Doettl SM, 792

Dorman MF, 731

Durieux-Smith A, 93

Dwyer RT, 235

Easterday M, 634, 792

Eikelboom RH, 217, 516

Entwisle L, 827

Escabi CD, 145

Fang X, 54

Farhadi M, 896

Feeney MP, 250

Ferguson MA, 417

Fischer ME, 282

Fitzpatrick EM, 93

Fitzpatrick J, 93

Flagge A, 31

Folkeard P, 227, 856

Folmer RL, 250

Fox A, 764

Frederick MT, 145, 406

Gaboury I, 93

Gaeta L, 845

Gaffney P, 550

Galster J, 315

Gardner A, 145

Gifford RH, 235, 918

Gilbane MS, 918

Glassman J, 273

Glista D, 552

Gopal KV, 431, 619

Gorga MP, 16

Goupell MJ, 659

Govindaswamy R, 744

Hallendorf L, 169

Harianawala J, 315

Harn WE, 810

Hatton K, 293

Hau O, 590

Hawkins M, 552

Haynes DS, 918

Heacock RM, 451, 871

Hedrick M, 103

Heeke P, 54

Heinze B, 482

Helmer D, 764

Herring CC, 54

Hoffer ME, 579

Hood LJ, 459

Hornsby B, 315

Hua N-Y, 672

Huang Y, 672

Huber A, 607

Hudson MA, 845

Hutcheson A, 431

Jacobson GP, 248, 450, 656

Jagadish N, 744

Janeteas C, 227

Jiang W, 672

Jilla AM, 677

John AB, 845

Johnson CE, 677, 845

Jones J, 431

Kaiser K, 431

Kallogjeri D, 502

Kapadia S, 264

Karayanidi K, 115

Kei J, 781

Kelley KS, 363

Kelly-Campbell RJ, 31

Kessler D, 235

Kitner BH, 357

Klein BEK, 282

Klein R, 282

Koch RW, 227

Kopun JG, 16

Korhonen P, 302, 590

Kuk F, 302, 590

Ladak HM, 227

Lake AB, 41

Langley LM, 208

Laszig R, 607

Leblond J, 720

Ledda KT, 502

Lee R, 93

Lehman M, 883

Lehmann A, 396

Lewis JD, 792

Liebenberg S, 781

Littenberg B, 363

Lo T-S, 187

Long GR, 459

Lu P, 672

Luo C-H, 187

Mahmoudian S, 896

Mahomed-Asmail F, 482

Maidment DW, 417

Makowiec K, 293

Malmstein E, 169

Manchaiah V, 31, 472, 810

Mann L, 883

Martindale AT, 856

Mathews L, 431

McCarron K, 764

McCaslin D, 293

McCaslin DL, 344, 550, 742

McCullough S, 431

McFarland DJ, 649

McMahon CM, 208

Mealings K, 533

Messersmith JJ, 827

Meyer CJ, 516

Mills LE, 619

Mohebbi M, 896

Montano JJ, 871

Montminy S, 720

Moodie S, 227

Moore BCJ, 772, 802

Moore DR, 6

Morency C-È, 720

Mosley CL, 208

Mülder HE, 607

Murfee J, 918

Musiek F, 451, 735

Muñoz K, 66, 444

Nagle S, 694

Nair E, 198

Nandy R, 619

Nassiri AM, 919

Natale SC, 731

Neeff M, 564

Neely ST, 16

Nelson L, 66

Nelson MD, 883

Nicholson C, 883

Nickerson A, 703

Nondahl DM, 282

Oeding K, 502

Olsson A, 169

Ong C, 444

Oree PH, 145

Osinubi O, 764

Pakulski LA, 273

Palmer S, 694

Pankow JS, 282

Parsa V, 552

Paulsen AJ, 282

Peck JE, 927

Penman T, 145

Phillips BS, 619

Picou EM, 131

Pigeon A, 451

Pilch S, 656

Plyler PN, 103, 634, 792

Pomponio ME, 694

Post CE, 54

Pourmand N, 552

Preminger JE, 871

Price T, 66

Purdy SC, 564

Quar TK, 346

Rajguru S, 579

Rasetshwane DM, 16

Rawool V, 78

Raybine DA, 16

Reed MB, 153

Ribera J, 178

Ricketts TA, 131

Riska K, 764

Roberts JB, 918

Romero DJ, 357

Roos M, 720

Roy J-S, 720

Salamatmanesh M, 93

Salvi R, 712

Sameshima K, 6

Sanchez KR, 677

Sanchez VA, 145

Satcher S, 764

Saunders G, 250

Saunders GH, 145, 406

Schafer EC, 431

Schmid F, 607

Schubert CR, 282

Scollie S, 227, 552

Scott M, 827

Searchfield GD, 327

Sell S, 250

Seper E, 302, 590

Shinn J, 493

Silverman SPC, 145, 406

Singh NK, 744, 753

Skoe E, 115

Slugocki C, 302, 590

Smart JL, 694

Smith KJ, 357

Snapp HA, 579

Sousa R, 198

Spahr A, 579

Spankovich C, 459

Speck I, 607

Squires ES, 273

Stoltz A, 482

Stuart A, 41

Sullivan JC, 677

Swanepoel DW, 217, 482

Tai C-C, 187

Tardy B, 103

Thirunavukkarasu K, 753

Thompson S, 431

Thorne PR, 564

Torre P, 153

Tremblay KL, 208

Trott S, 493

Tseng C-L, 764

Tweed TS, 282

Twohig M, 66

Twohig MP, 444

Uchanski RM, 703

Umat C, 346

Vachhani J, 250

Vaisberg JM, 552, 856

Valente M, 502

van Steenbrugge W, 264

Vermiglio AJ, 54

Waechter S, 169

Wang B, 672

Wang Y, 672

Wannagot S, 198

Warren S, 827

Weihing J, 451, 493, 735

Wesarg T, 607

Westermann LC, 145

Whicker JJ, 444

Whittingham JA, 93

Wiebe K, 607

Wilson MJ, 357

Wilson RH, 370

Xu Z-M, 672

Yawn RJ, 918

Zaleski-King A, 659

Key Words

(central) auditory processing, 694

(central) auditory processing disorder, 694

achieved gain, 346

action potential, 41

adaptive test, 315

adults, 552

adult children, 93, 677, 871

adverse childhood experiences, 772

AEMT, 315

Africa, 178

age-related hearing loss, 145, 208, 250, 273, 417

aging, 208, 217, 845

agreement, 363

aided audibility index, 16

air conduction oVEMP, 753

american academy of audiology guidelines, 827

amplification, 93, 502

amplitude modulation, 533

anxiety, 802

assessment, 792, 845

assistive listening device, 187, 579

attention, 451

audiologists, 677

audiology, 54, 178, 250, 810

audiometry, 208, 482

auditory neuropathy, 672

auditory perception, 370

auditory plasticity, 564

auditory processing disorder, 6, 904

auditory processing disorders, 451, 904

auditory rehabilitation, 198, 250, 406, 871

auditory steady-state response, 672

auditory training, 431

autism spectrum disorder, 431

automated audiometry, 217

axonal conduction time, 904

balance, 883

beamformer, 731

best practice guidelines, american academy of audiology, 827

bilingual, 115

Bluetooth, 187

brong-ahafo regional hospital, 178

Caucasian, 78

central auditory function, 282

central auditory processing disorder, 493, 904

cervical dysfunction, 720

childhood hearing loss, 178, 250, 273, 417, 703

children, 6, 552, 677, 94

chirp, 396

click-evoked ABR, 904

client oriented scale of improvement, 327

clinical consultation, 810

clinician-client communication, 810

cochlear implant, 235, 396, 731

cochlear implant guidelines, 827

cochlear implantation, 607, 918

cochlear implants, 198, 235, 396, 607, 659, 677, 703, 731, 827

cochlear microphonics, 672

cognitive load, 264

cognitive performance, 169

COM-B model, 417

communication, 810

communication partners, 810, 871

compression speeds, 590

confidence, 66

content validity, 227

contralateral routing of signal, 235, 579

conversation analysis, 810

cortical auditory evoked potential, 564

counseling, 66, 406, 677

CROS, 235

culture, 78

decision consistency, 363

depression, 802

diabetes, 459

diagnostic audiometry, 217

dichotic listening, 264, 451, 579

dichotic listening tests, 282, 363, 579

digital noise reduction, 103, 131

directional microphone, 731

distortion product otoacoustic emissions, 178

distortion product otoacoustic emissions screening, 178, 250

divided attention, 264

dizziness, 764

duration pattern test, 6

earplugs, 78

education, 227, 273

electrically evoked compound action potential, 918

electrocochleography, 41

electrode, 41

electrode montage, 357

electronystagmography, 883

electrophysiology, 451

epidemiology, 282

Etymotic, 208

eustachian tube dysfunction, 781

exercises, 720

extended high frequencies, 217

extended input dynamic range, 634

eye movements, 883

face shadow effect, 235

face validity, 227

fast-acting compression, 590

Filipino, 78

fine structure, 459

fit-to-targets, 346

frequency lowering, 552

Ghana, 178

goal planning, 327

Gulf War Illness, 764

habituation, 896

head shadow effect, 235

health care, 273

health information quality, 31

hearing, 250

health information readability, 31

hearing aid management, 250, 634

hearing aid, 103, 131, 516

hearing aid satisfaction, 103, 131, 302, 634

hearing aids, 16, 93, 103, 131, 227, 250, 417, 472, 502, 516, 552, 634, 703, 856

hearing aids and assistive listening devices, 93, 103, 131, 198, 227, 250, 406, 417, 552, 579, 634, 659, 703,

hearing health care, 208, 250

hearing health-care uptake, 208, 250

hearing healthcare, 250

hearing loss, 131, 250, 273, 417, 472, 482, 703, 845, 856

hearing preservation, 250, 918

hearing protection devices, 78, 250

hearing science, 659

hearing screening, 145, 178, 250

HHC, 871

HI, 871

high-frequency hearing, 169, 250

HINT, 315

Home Hearing Test, 208

human immunodeficiency virus, 482

hyperacusis, 712, 772, 802

infant hearing screening, 145, 178, 250

initial-fit, 346

insomnia, 802

instantaneous compression, 16

instrumentalists, 856

interaction analysis, 810

internet health information, 31

ipod, 619

kiosk, 250

Korle-bu Teaching Hospital, 178

large vestibular aqueduct syndrome, 677, 792

latency, 357

listening, 580

listening levels, 153

loud music, 78

Mandarin monosyllable recognition test, 187, 590

manual therapy, 720

manufacturer fitting, 346

masking release, 16

maximum amplitude, 918

medial olivocochlear reflex, 792

memory demands, 264

menopause, 493

mHealth, 217

middle latency responses, 396

mild hearing loss, 93, 131

mixed methods, 516

mobile health, 482

MOCR, 792

monaural, 579

music perception, 856

musician, 78

musicians, 856

n-back, 169

N1-P2, 451

N10 amplitude, 357

negative effects, 472

newborn hearing screening, 178, 250, 145

noise, 131, 459

noise-induced hearing loss, 217, 250, 273, 417, 703

nonlinear frequency compression, 103, 552

normal hearing, 169, 250

normal hearing for pure tones, 370

nystagmus, 883

older adults, 208, 552, 753

otoacoustic emission, 459

otoacoustic emissions screening, 178, 250

otolith, 357

ototoxicity, 217

outcomes, 516

oVEMP, 293

parental mental health, 772

parental separation, 772

parents, 677

patient perspective, 856

patient-centered care, 810

pediatric, 703, 810

pediatric audiology, 66, 178, 198, 250

performance-intensity functions, 315

personal audio systems, 619

phase-locking, 357

photo voice, 406

physicians, 677

pitch pattern test, 6

positional nystagmus, 883

posttraumatic stress disorder, 764

presbycusis, 208

prescribed gain, 346

probe tube placement, 227

psychological assessment, 712, 792

psychosocial concerns, 810

public health, 208

pure-tone hearing thresholds, 712

pure-tone thresholds, 54, 619, 918

qualitative, 856

questionnaire, 327, 896

R-SPACE™, 235

rate processing, 533

reading difficulties, 533

real-ear, 227

real-ear measures, 346

recreational noise–induced hearing loss, 131, 619, 703

reliability, 302

reliability and validity, 694

remote microphone technology, 431

remote wireless microphone system, 607

residual hearing, 250, 918

response amplitude, 357

response filter set, 753

risk factors, 153

saccades, 744

SCDS, 293

scoring methods, 694

screening, 250

selective attention, 264

self-report, 131, 145

self-reported hearing, 564

self-test, 208

sensorineural hearing loss, 131, 370, 417, 677, 703

sensory gating, 896

shared decision-making, 810

side effects, 472

SII, 703

simulation, 227

single-sided deafness, 607

slow-acting compression, 590

smartphone, 217

smartphone-connected listening devices, 417, 579

somatosensory tinnitus, 720, 772

sound localization, 564

sound quality, 552

spatial advantage, 54

spatial processing, 451

spectro-temporal processing, 533

speech in noise, 115

speech in noise test, 131, 315

speech perception, 131, 370

speech recognition abilities, 564, 590

speech recognition in noise ability, 54, 131, 459, 590, 607, 845

SSQ, 564

static, 883

stimulus polarity, 357

stimulus rate, 41

student, 273

sub-Saharan Africa, 178

summating potential, 41

superior canal dehiscence, 293

synaptic transmission time, 904

synchronous telehealth model, 178, 208

task-evoked pupil response, 264

tasking, 792

technology assessment, 363, 792

tele-audiology, 178, 250, 810

teleaudiology, 208, 250, 810

telecoil, 502

telehealth, 178, 208

telemedicine, 178

telephone, 502

telephony, 187

temporal sampling, 533

temporary threshold shift, 619

TEOAE, 792

test-retest reliability, 744

test–retest variability, 41

Theoretical Domains Framework, 417

tinnitus, 802

tinnitus, 31, 169, 327, 772, 802, 896

tinnitus functional index, 327, 772, 802

tinnitus handicap inventory, 327, 772, 802

tinnitus handicap questionnaire, 327, 772, 802

tinnitus loudness, 712, 772, 802

tolerable noise level, 131, 302

tracking of noise tolerance, 131, 302

training, 227

transient evoked otoacoustic emissions, 792

uncomfortable loudness levels, 712

unilateral cochlear implant, 579, 607, 731

unilateral hearing loss, 93, 131, 235, 250, 273, 417, 564, 703

utricle, 293, 357, 753

variable speed compression, 590

vascular health–related factors, 282

verification, 703

vertigo, 764

vestibular, 293, 792, 884

vestibular evoked myogenic potential, 357, 792

vestibulo-ocular reflex, 792

veterans, 764

vHIT, 744

videonystagmography, 883

VNG, 792

VOR, 792

VOR gain, 744

wideband absorbance, 781

word recognition, 370, 590

working memory, 169

young adults, 153

No conflict of interest has been declared by the author(s).